Maintenance chemotherapy for childhood acute lymphoblastic leukemia: should dosage be guided by white blood cell counts?

Keyphrases

• 6-mercaptopurine (6-MP) 50%
• B-cell Acute Lymphoblastic Leukemia (B-ALL) 25%
• Bone Marrow Relapse 25%
• Childhood Acute Lymphoblastic Leukemia 100%
• Clinical Benefit 50%
• Dose Adjustment 25%
• Leukopenia 75%
• Low Risk 25%
• Maintenance Chemotherapy 100%
• Methotrexate 25%
• Oral Methotrexate 25%
• Population-based Study 25%
• Prescribed Dose 25%
• Relapse Risk 25%
• Remission 25%
• White Blood Cell Count 100%
• Working Diagnosis 25%
• Year of Diagnosis 25%

Medicine and Dentistry

• Acute B-Cell Lymphoblastic Leukemia 20%
• Acute Lymphoblastic Leukemia 100%
• Cell Count 100%
• High Risk Population 20%
• Leukocyte 100%
• Leukopenia 60%
• Maintenance Chemotherapy 100%
• Mercaptopurine 40%
• Methotrexate 40%
• Prospective Study 20%

Immunology and Microbiology

• B Cell 25%
• High Risk Population 25%
• Leukocyte 25%
• Leukocyte Count 100%
• Methotrexate 50%